Literature DB >> 28258424

Patients with negative multi-gene panel testing: a back to the future paradox?

Steven M Sorscher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28258424     DOI： 10.1007/s10689-017-9967-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


× No keyword cloud information.
  2 in total

1.  Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.

Authors:  David J Hermel; Wendy C McKinnon; Marie E Wood; Marc S Greenblatt
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

2.  Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Authors:  Mary B Daly; Robert Pilarski; Jennifer E Axilbund; Michael Berry; Saundra S Buys; Beth Crawford; Meagan Farmer; Susan Friedman; Judy E Garber; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; P Kelly Marcom; Sofia D Merajver; Kenneth Offit; Tuya Pal; Huma Rana; Gwen Reiser; Mark E Robson; Kristen Mahoney Shannon; Elizabeth Swisher; Nicoleta C Voian; Jeffrey N Weitzel; Alison Whelan; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Rashmi Kumar; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2016-02       Impact factor: 11.908
  2 in total
  1 in total

1.  Placing negative multi-gene panel results into clinical context.

Authors:  David J Hermel; Wendy C McKinnon; Marie E Wood; Marc S Greenblatt
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.